Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  INDONESIA STOCK EXCHANGE  >  Kalbe Farma Tbk PT    KLBF   ID1000125107

KALBE FARMA TBK PT

(KLBF)
  Report
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Indonesia hikes state health insurer's premiums to plug deficit

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2019 | 05:21am EST

JAKARTA (Reuters) - Indonesia's state health insurer will raise regular customers' premiums starting 2020 to patch up deficits and the government will chip in to cover this year's $2.3 billion estimated cash shortfall, according to a government statement on Wednesday.

The burden of supporting the state-owned agency providing some of the biggest health system in the world has become a growing fiscal risk for Southeast Asia's largest economy.

BPJS Kesehatan, which provides universal health coverage for over 200 million people, has been facing cash problems not long after its inception in 2014, regularly booking claims far exceeding premiums it collects. The premiums are regulated by the government.

BPJS is set to record a 32 trillion rupiah ($2.28 billion) cash deficit at the end of the year without government help and this may grow more than two-fold to 77 trillion by 2024, company executives have warned.

Starting next year, the government will raise premiums for the cheapest insurance package by 65% to 42,000 rupiah a month and two other packages by more than 100% to 110,000 rupiah and 160,000 rupiah per month, according to a statement by the Cabinet Secretariat.

There will be additional funds given to the insurer by the state this year, as the regulation calls for a retroactive increase from August of state-covered premiums for 133 million poor and vulnerable people by 83% to 42,000 rupiah a month.

Askolani, director general of budgeting at the finance ministry, said the government was still calculating how much it would have to transfer to BPJS based on the new rules.

BPJS chief executive Fachmi Idris did not respond to a request for comment.

The finance ministry had originally planned for an increase for the cheapest package to start in September, but after receiving backlash from trade unions, President Joko Widodo ordered for this to be reviewed.

Muhammad Nafan Aji, a Binaartha Sekuritas analyst, said the premium increase can be a positive catalyst for listed companies in healthcare and pharmaceutical, such as hospital operator Mitra Keluarga Karyasehat and Kalbe Farma.

"Billing payments to BPJS will be more flexible, easier," Aji said, adding that better financial position would allow the insurer to pay hospitals on time, ensuring payments to pharmaceutical companies as well.

Last year, the government ordered an audit into BPJS after it injected 10.1 trillion rupiah to help the insurer manage its cashflow. State auditors have given BPJS executives some recommendations to improve governance to get the company out of the red.

($1 = 14,040.0000 rupiah)

(Reporting by Tabita Diela; Additional reporting by Maikel Jefriando; Writing by Gayatri Suroyo; Editing by Muralikumar Anantharaman)

Stocks mentioned in the article
ChangeLast1st jan.
HUDSON'S BAY COMPANY 0.00% 10.9 Delayed Quote.10.32%
KALBE FARMA TBK PT End-of-day quote.
MITRA KELUARGA KARYASEHAT TBK PT End-of-day quote.
UNIVERSAL HEALTH SERVICES 1.00% 145.39 Delayed Quote.0.33%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on KALBE FARMA TBK PT
2019KALBE FARMA TBK PT : Disclosure of Information - Increased in Issued and Paid in..
PU
2019KALBE FARMA TBK PT : Disclosure of Information - Increased in Issued and Paid in..
PU
2019KALBE FARMA TBK PT : Growth Improvement in Sales and Net Income
PU
2019Indonesia hikes state health insurer's premiums to plug deficit
RE
2019KALBE FARMA TBK PT : Disclosure of Information - Establishment of a Subsidiary, ..
PU
2019KALBE FARMA TBK PT : Will Participate In CPhI In Frankfurt
PU
2019KALBE FARMA TBK PT : Commemorates World Hepatitis Day
PU
2019KALBE FARMA TBK PT : Genexine Biologics Enters Into an Exclusive Licensing of Im..
PU
2019KALBE FARMA TBK PT : Maintain Better Company Performance
PU
2019KALBE FARMA TBK PT : Ex-dividend day for final dividend
FA
More news
Financials (IDR)
Sales 2019 22 850 B
EBIT 2019 3 526 B
Net income 2019 2 687 B
Finance 2019 2 696 B
Yield 2019 1,63%
P/E ratio 2019 28,2x
P/E ratio 2020 26,7x
EV / Sales2019 3 313x
EV / Sales2020 3 085x
Capitalization 75 703 B
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 1 740,83  IDR
Last Close Price 1 615,00  IDR
Spread / Highest target 23,8%
Spread / Average Target 7,79%
Spread / Lowest Target -25,7%
EPS Revisions
Managers
NameTitle
Vidjongtius President Director
Bernadette Ruth Setiady President Commissioner
Dino Bramanto Head-Corporate Information Technology & System
Santoso Oen Commissioner
Ferdinand Aryanto Commissioner
Sector and Competitors
1st jan.Capitalization (M$)
KALBE FARMA TBK PT5 723
JOHNSON & JOHNSON0.78%385 622
ROCHE HOLDING AG2.21%283 936
MERCK AND COMPANY0.25%228 960
PFIZER3.65%221 752
NOVARTIS-0.29%215 061